tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Tim Lugo, 21 are a BUY (67.74%), 10 are a HOLD (32.26%).
Analyst Tim Lugo, carries an average stock price target met ratio of 57.41% that have a potential upside of 44.05% achieved within 738 days. Previously, Tim Lugo worked at WILLIAM BLAIR.
Tim Lugo’s has documented 55 price targets and ratings displayed on 18 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on BMRN, Biomarin Pharmaceutical at 30-Oct-2024.
Analyst best performing recommendations are on EGRX (EAGLE PHARMACEUTICALS).
The best stock recommendation documented was for SRPT (SAREPTA THERAPEUTICS) at 3/20/2013. The price target of $52 was fulfilled within 198 days with a profit of $19.23 (58.68%) receiving and performance score of 2.96.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
$75
$-31.28 (-29.43%)
$75
9 days ago
(13-Feb-2025)
0/5 (0%)
$-34.46 (-31.48%)
Buy
$202
$95.72 (90.06%)
$202
26 days ago
(27-Jan-2025)
11/27 (40.74%)
$85.11 (72.81%)
349
Buy
$182
$75.72 (71.25%)
$200
2 months 26 days ago
(27-Nov-2024)
2/5 (40%)
$44.06 (31.94%)
13
Buy
$193
$86.72 (81.60%)
$200
3 months 15 days ago
(07-Nov-2024)
41/57 (71.93%)
$72.58 (60.27%)
290
Buy
$150
$43.72 (41.14%)
$103
3 months 15 days ago
(07-Nov-2024)
2/4 (50%)
$29.58 (24.56%)
249
Which stock is Tim Lugo is most bullish on?
What Year was the first public recommendation made by Tim Lugo?
